Navigation Links
Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
Date:2/22/2011

ping universal influenza and other vaccines in collaboration with scientists from the University of Pennsylvania. Other partners and collaborators include Merck, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, University of Southampton, and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
2. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
3. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
4. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 3, 2015  VirtualScopics, Inc. (NASDAQ: VSCP ... solutions, announced today, they are collaborating with a ... philanthropic, epidemiology study partnering with the Ministry of ... has teamed up with a cardiac sonographer to ... results will be used to identify children with ...
(Date:9/3/2015)... SEATTLE , Sept. 3, 2015  Omeros Corporation ... filed patent infringement lawsuits against Par Pharmaceutical, Inc. and ... the U.S. District Court for the District of ... District Court for the District of Delaware ... Act for Par,s infringement of three Omeros patents, U.S. ...
(Date:9/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hs5hvr/investigation ... "Investigation Report on China Tamsulosin Market, 2010-2019" ... with other a1- adrenergic receptor blockers, tamsulosin hydrochloride ... risk of urinary tract infections and therefore is ... in 1993 in Japan , ...
Breaking Medicine Technology:VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 2VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 3VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 4Omeros Files Infringement Suits Against Par 2Omeros Files Infringement Suits Against Par 3Omeros Files Infringement Suits Against Par 4China Tamsulosin Market Investigation Report 2015 2
... Holdings, Inc. (NYSE and SIX: ZMH), a global leader ... in the 2011 Morgan Stanley Global Healthcare Unplugged Conference ... September 13, 2011, at 9:10 a.m. Eastern Time. ... be accessed via Zimmer,s Investor Relations website at ...
... Sept. 1, 2011 Hill-Rom Holdings, Inc., (NYSE: ... management presentation at the Morgan Stanley Global Healthcare Conference ... 8:35 a.m. ET. You are invited to ... at http://ir.hill-rom.com/events.cfm or access it directly at ...
Cached Medicine Technology:Zimmer Holdings to Present at 2011 Morgan Stanley Global Healthcare Unplugged Conference 2
(Date:9/3/2015)... ... 03, 2015 , ... DriButts, a non-profit organization dedicated to ... Development Group to manufacture a long-lasting reusable diaper for warm weather climates where ... bring 600 DriButts Diapers to rural areas of Haiti during a trip scheduled ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... Scholarship applications are open for spring 2016. Scholarships are awarded two times each ... For The Warriors® is a national nonprofit dedicated to restoring a sense of ...
(Date:9/3/2015)... Columbus, Ohio (PRWEB) , ... September 03, 2015 ... ... Hartley ( http://www.tamarahartley.com ) announces the release of her debut book, “Stop Wasting ... National Read a Book Day (September 6), Hartley’s guide to overcoming life’s obstacles ...
(Date:9/3/2015)... Bellevue, WA (PRWEB) , ... ... ... Center of Washington, a leading provider of comprehensive eating disorder treatment for ... illnesses, announced today that Ileana Calinoiu, MD has joined the medical treatment ...
(Date:9/3/2015)... ... September 03, 2015 , ... As a result ... fully insured employer-sponsored health insurance plans, more employers are moving to a self-funded ... released from the 2014 United Benefit Advisors (UBA) Health Plan Survey. , UBA’s ...
Breaking Medicine News(10 mins):Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 2Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 4
... in Favor of Kentucky Oil, BETHEL, Conn., ... a leading provider of nitinol and polymer components ... has received an,unfavorable jury verdict in its disputed ... that Memry breached a,collaboration agreement by providing confidential ...
... YORK (Dec. 20, 2007) -- Using new approaches, an ... Center in New York City has gained a view ... core difficulty in patients with borderline personality disorder -- ... "It,s early days yet, but the work is pinpointing ...
... HeartCentrix(R) ECG Informatics Makes Results from Burdick(R) and, Quinton(R) branded products ... ... 5.0, BOTHELL, Wash. ... ), a leading provider of cardiac,monitoring, defibrillation and rehabilitative products, and ...
... -- Discovery Health Partners with Kashi, America,s Milk Processors and, ... Online and in the ... No Cost to the Participant --, SILVER SPRING, Md., ... to help battle the obesity epidemic,with its biggest and best ...
... study finds that most general surgeons do not discuss ... analysis shows that only one in three patients eligible ... The study is published in the February 1, 2008 ... Cancer Society. , The option of breast reconstruction has ...
... Dec. 20 The Campaign to End,Obesity (the ... 2008 Democratic,and Republican presidential candidates failed to respond ... address the Nation,s obesity epidemic,if elected. Only Senators ... the Campaign,s questionnaire, which was distributed to the,candidates, ...
Cached Medicine News:Health News:Memry Corporation Plans to Appeal Unfavorable Court Result 2Health News:Memry Corporation Plans to Appeal Unfavorable Court Result 3Health News:Scientists identify brain abnormalities underlying key element of borderline personality disorder 2Health News:Scientists identify brain abnormalities underlying key element of borderline personality disorder 3Health News:Scientists identify brain abnormalities underlying key element of borderline personality disorder 4Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 2Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 3Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 4Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 5Health News:Discovery Health's Fifth Annual National Body Challenge Takes a Stand Against Obesity by Offering the Keys to Adopting a Healthy, Active Lifestyle 2Health News:Discovery Health's Fifth Annual National Body Challenge Takes a Stand Against Obesity by Offering the Keys to Adopting a Healthy, Active Lifestyle 3Health News:Reconstruction surgery rarely discussed with breast cancer patients 2Health News:2008 Presidential Hopefuls Fail to Respond to Questions About Obesity in U.S. 2
... and Maximum ACT introducers represent the ... hemostasis introducers in the world. They ... introducers for use in interventional cardiology ... stenting, atherectomy, temporary pacing, endomyocardial biopsies, ...
... hemostasis introducers provide outstanding insertion ... dilator-to-sheath transitions, high kink resistance ... dual layer sheath cannula provides ... works with an extra strong ...
Bx VELOCITY Coronary Stent with HEPACOAT...
A steerable diagnostic catheter with optimal maneuverability...
Medicine Products: